Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_provenance.
- NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_assertion description "[Our data suggest that transactivation of CDCA5 and its phosphorylation at Ser209 by ERK play an important role in lung cancer proliferation, and that the selective suppression of the ERK-CDCA5 pathway could be a promising strategy for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_provenance.
- NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_assertion evidence source_evidence_literature NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_provenance.
- NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_assertion SIO_000772 20551060 NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_provenance.
- NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_assertion wasDerivedFrom befree-20140225 NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_provenance.
- NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_assertion wasGeneratedBy ECO_0000203 NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_provenance.
- befree-20140225 importedOn "2014-02-25" NP759265.RAfBica_YZKR1o5w-E5H0LdJdB9GNDTlveO24LDnZ2s3M130_provenance.